Steven H Holtzman
CIK 1300247 · EVP Corporate Development · last filed 2025-06-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.12M
Companies
4
Total Filings
47
Lifetime Open-Market Net
-$7.36M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CAMP | Director | 108,946 | $4.19 | $456.5K | $0 | 2 | 2025-06-27 |
| BIIB | EVP Corporate Development | 8,326 | $200.05 | $1.67M | -$4.22M | 24 | 2016-02-25 |
| INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Director | 3,945 | $0.04 | $176 | -$3.14M | 15 | 2012-06-04 |
| ANADYS PHARMACEUTICALS INC (ANDS) Delisted | Director | — | — | — | $0 | 6 | 2010-05-28 |
Recent Filings · Page 4 of 5
47 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-01-07 | INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-12-13 | INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Grant (A) | +100,000 | $0 | EDGAR |
| 2010-05-28 | ANADYS PHARMACEUTICALS INC (ANDS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-01-07 | INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-10-06 | ANADYS PHARMACEUTICALS INC (ANDS) Delisted | Other (J) | — | $0 | EDGAR |
| 2009-05-29 | ANADYS PHARMACEUTICALS INC (ANDS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-01-07 | INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-01-07 | INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Exer (M) | +33,154 | $115.4K | EDGAR |
| 2008-12-08 | INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-10-29 | INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Exer (M) | +88,742 | $229.3K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.